Omeros OMER
NASDAQ OMER
$16.29 -0.26 (-1.57%)
As of: Oct 21, 2026 · 2:41 PM EDT

Omeros (OMER) Shares Repurchased (2023 - 2026)

Updated

Analysis

Omeros (OMER) Shares Repurchased (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Eli Lilly 1,136.90 Bn 1,105.48 Bn 19.71 Bn 1.60 Bn
2 Johnson & Johnson 617.06 Bn 535.59 Bn 17.26 Bn 221.00 Mn
3 AbbVie 501.38 Bn 474.49 Bn 12.70 Bn 9.00 Mn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 757.00 Mn
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn 1.20 Bn
6 Astrazeneca 261.31 Bn 235.00 Bn 12.86 Bn -
7 Amgen 236.29 Bn 191.69 Bn 7.24 Bn -
8 Gilead Sciences 190.40 Bn 164.60 Bn 6.22 Bn 355.00 Mn
9 Pfizer 169.55 Bn 116.19 Bn 10.94 Bn -
10 Omeros 1.18 Bn 733.97 Mn 27.73 Mn 5.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.73 Mn
Mar 31, 2026 4.15 Mn
Mar 31, 2024 11.85 Mn
Dec 31, 2023 4.65 Mn
API Access

Omeros Shares Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-repurchased&ticker=OMER&period=max&api_key=YOUR_API_KEY